SEC Form 4 · accession 0001493152-17-006429
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Yanover
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 9, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $6.31 | Jun 8, 2017 | A | 400 | A | Jul 8, 2017 | Jun 7, 2027 | Common Stock | 400 | 400 | D |
Explanation of responses
- F1Stock option granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. The options vest and become exercisable in 12 equal monthly installments from the date of grant.